Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2026-06-01 @ 4:48 AM
Study NCT ID:
NCT01539018
Status:
TERMINATED
Last Update Posted:
2015-08-05
First Post:
2012-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE
Sponsor:
Organization: